Franchise Cannabis’s German Subsidiary ACA Müller Commits to Purchase of Medical Cannabis from MJardin’s Halifax Facility Due to Rapid Growth in German Patient Demand

DENVER, Colorado, and TORONTO, Canada, -- September 16, 2019 - MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, announces a supply contract with ACA Müller ADAG Pharma Vertriebs GmbH (“ACA Müller”), a subsidiary of Franchise Cannabis Corp. (“Franchise”), for the supply offtake of a total of 2,250 kg of medical cannabis over a nine month period in 2020 from MJardin’s 48,000 square foot Halifax facility (“AMI”)*. ACA Müller has committed to purchase 250 kgs a month of high THC (>20%) medical cannabis flower during Q1 to Q3 2020 at a set price throughout the year. AMI remains on track for EU GMP Certification by the end of this year and is expected to add an additional 20,000 square feet by Q1 2020.

MJardin Group Announces Second Quarter 2019 Financial Results and Conference Call

DENVER, Colorado, and TORONTO, Canada, August 29, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today announced its financial and operating results for the quarter ending June 30, 2019. All amounts are expressed in Canadian dollars unless otherwise indicated.

 

·       Second quarter revenue of $7.6 million and YTD revenues of $17.7 million;

·       Successfully implemented cost reductions announced in Q1 with a 47% reduction in SG&A compared to prior quarter;

·       Announced acquisition of Carson City Agency Solutions dba as Cannabella (“Cannabella”), a leading Nevada provider of edible and other derivative products;

·       Completed first sale at Halifax, Nova Scotia facility “AMI”, and remain ahead of schedule on Phase 1, with Phase 2 expected to come online by the end of the fourth quarter, 2019;

·       Completed construction at MJardin’s “GRO” facility in Dunnville, Ontario and submitted Evidence of Readiness for Health Canada approval and issuance of Cultivation and Processing license;

·       Continued production of high THC cultivars from the WILL facility with THC content testing between 21.0%-28.0%; 

·       Production metrics at our AMI and WILL facility continue to produce at approximately 60 grams per square foot.

MJardin Group Announces Design Finalization and Signing of Non-Binding Warman Letter of Intent

DENVER, Colorado, and TORONTO, Canada, August 28, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today announced it has finalized the design for its Warman Road project in Winnipeg, Manitoba (“Warman”), a hybrid facility encompassing indoor and greenhouse production along with full EU GMP certified extraction, processing and packaging capabilities. The Company also announced the signing of a non-binding Letter of Intent (“LOI”) with Peguis First Nation (“Peguis”) for a Joint Venture (“JV”) in connection with the operation and ownership of Warman.

RAMA First Nation and MJardin Group Release Designs for Combination Indoor/Greenhouse Cannabis Campus

TORONTO, Canada and DENVER, Colorado, July 31, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today released, with its joint-venture partner the Chippewas of Rama First Nation (51%), designs of their 94,650 sq. ft. cannabis campus to be located in the community of Rama, Ontario.

 The campus will be a combination of indoor/greenhouse cultivation with interior space of 62,400 sq. ft containing six cultivation rooms for production of high-end flower, all necessary cultivation support spaces, a 5,500 sq. ft GMP certified extraction facility, a cannabis education centre and a retail dispensary. In addition, two greenhouses equaling 32,250 sq. ft. will be dedicated to producing extractable biomass.

MJardin Group Receives Transfer of License Agreement Resulting in Full Ownership Status of Nevada Cultivation Facility

DENVER, Colorado, and TORONTO, Canada, July 23, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today announced it has successfully closed and received the ownership transfer of license for its Cheyenne Ave., Las Vegas, Nevada cultivation facility (the “Facility”) from GreenMart of Nevada, LLC (“GreenMart”), providing the Company with its first 100% owned and operated cultivation facility in Nevada.

MJardin Group Announces Closing of Sale-Leaseback Transaction for US$9.6 million

DENVER, Colorado, and TORONTO, Canada, July 17, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today announced  it has closed a sale-leaseback agreement with Innovative Industrial Properties (“IIP”) (NYSE:IIPR) worth an estimated value of US$9.6 million (excluding transaction costs) of its Cheyenne Ave., Las Vegas, Nevada production facility owned by the Company (the “Facility”).

MJardin Group Appoints Interim Chief Financial Officer & Reports Board of Directors Appointments Following its Annual General Meeting of Shareholders

TORONTO, Canada and DENVER, Colorado, July 16, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today announced the appointment of Wendy Xue, MJardin’s current Global Controller, as interim Chief Financial Officer effective August 1, 2019, following the departure of the Chief Financial Officer Chris Seto from the Company. As Interim Chief Financial Officer, Ms. Xue will report directly to Adrian Montgomery, Chief Executive Officer of MJardin, until a permanent replacement is named.

MJardin Group to Issue Second Quarter 2019 Financial Results August 29, 2019

TORONTO, Canada and DENVER, Colorado, July 9, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), is pleased to announce that it will report its second quarter 2019 financial results for the period ended June 30, 2019, before market open on August 29, 2019.

 The Company will host a conference call the same day at 10:00 am ET. The senior management team will discuss the Company’s financial performance for the period ended June 30, 2019. To access the call, please dial 1-888-254-3590 or 1-323-994-2093. A replay of the conference call will be available from 1:00 pm ET on August 29, 2019, until 11:59 pm ET, September 12, 2019. To access the replay, dial 1-844-512-2921 or 1-412-317-6671, followed by passcode 6287281.

A webcast link to the call is available at the following URL: http://public.viavid.com/index.php?id=135285

MJardin’s Atlantic Canada Facility Completes Multiple Harvests at Full Capacity; Yield Projections Ahead of Schedule as Phase 2 Expansion Underway

TORONTO, Canada and DENVER, Colorado, June 26th, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), is pleased to announce its AtlantiCann Medical Inc. (“AMI”)  facility has reached full production capacity at 3 harvests per month with consistent yields and is ahead of schedule for reaching its annual target rates. “AMI” is a three-way partnership consisting of Nova Scotia Mi’kmaq First Nations (51%), MJardin Group, Inc. (39%) and the Halef Group (10%).

The 48,000 square foot cultivation facility has successfully reached three harvests per month and is ahead of schedule to meet its annual target rate of 3,500kg production capacity per year. May’s total output of three harvests resulted in 418 kg of dry untrimmed flower in 4,875 square feet of bench space and June is on pace to result in similar yields of over 400 kg. THC rates are averaging close to 20% with some varieties as high as 25%.

MJardin Group Announces First Quarter 2019 Financial Results and Conference Call

DENVER, Colorado, and TORONTO, Canada, May 30, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today announced its financial and operating results for the quarter ending March 31, 2019. All amounts are expressed in Canadian dollars unless otherwise indicated.

·       Generated revenues of $10.9 million;

·       Increased monthly production at the Brampton, Ontario facility “WILL” by 50% to a run-rate of approximately 700 kg of dried flower;

·       Continued retrofit of remaining nine grow rooms at WILL, construction to be completed by the third quarter and revised production estimates to approximately 2,200 kg of dried flower annually;

·       Completed first harvest at Halifax, Nova Scotia facility “AMI”, fully propagated all grow rooms and remain on track to have AMI at full harvest levels by the fourth quarter of 2019;

·       Completed previously announced definitive agreement with Rama First Nation for the development of a cultivation, extraction and retail facility located adjacent to Casino Rama;

·       Company began publicly trading on the OTC under ticker symbol MJARF.